Cases 161 - 170 of 241
NOVARTIS AG et al v. AUROBINDO PHARMA LTD. et al
as 2:2017cv00389
Plaintiff:
NOVARTIS AG , NOVARTIS PHARMACEUTICALS CORPORATION , MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 15 U.S.C. § 1126
AbbVie Inc. et al v. Aurobindo Pharma Limited et al
as 1:2017cv00047
Plaintiff:
AbbVie Inc. and Abbvie Deutschland GMBH & Co. KG
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis AG et al v. Aurobindo Pharma Ltd. et al
as 1:2017cv00048
Plaintiff:
Novartis AG , Novartis Pharmaceuticals Corporation , Mitsubishi Tanabe Pharma Corporation and others
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 145
Sanofi-Aventis U.S. LLC et al v. Aurobindo Pharma USA, Inc., et al.
as 1:2016cv01299
Plaintiff:
Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
MERCK, SHARP & DOHME CORP. et al v. AUROBINDO PHARMA LTD. et al
as 3:2016cv09033
Plaintiff:
MERCK, SHARP & DOHME CORP. , BRISTOL-MYERS SQUIBB COMPANY and BRISTOL-MYERS SQUIBB PHARMA CO.
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2016cv01114
Plaintiff:
Forest Laboratories, LLC , Forest Laboratories Holdings, Ltd. , Allergan USA, Inc. and others
Defendant:
Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc. , Sandoz Inc. and others
Cause Of Action: 35 U.S.C. § 271
Astellas Pharma Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2016cv00942
Plaintiff:
Astellas Pharma Inc. , Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Defendant:
Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. and Aurolife Pharma LLC
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2016cv00886
Plaintiff:
Pfizer Inc. and UCB Pharma GmbH
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. v. Amneal Pharmaceuticals et al
as 1:2016cv00853
Defendant:
Aurobindo Pharma Ltd, Cadila Healthcare Ltd. doing business as Zydus Cadila, Hetero USA Inc. and others
Plaintiff:
Amgen Inc.
3Rd Party Defendant:
Alkem Laboratories Ltd. and Ascend Laboratories, LLC
Counter Claimant:
Cadila Healthcare Ltd.
Cause Of Action: 35 U.S.C. § 271
Eli Lilly and Company et al v. Aurobindo Phrama Ltd. et al
as 1:2016cv01121
Plaintiff:
Eli Lilly and Company and ICOS Corporation
Defendant:
Aurobindo Phrama Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
